Taylor & Francis Group published an article collection entitled Early phase drug development for underrepresented hematological disease: Challenges and clinical translation.

Taylor & Francis Group partners with researchers, scholarly societies, universities and libraries worldwide to bring knowledge to life. As one of the world’s leading publishers of scholarly journals, books, ebooks and reference works our content spans all areas of Humanities, Social Sciences, Behavioural Sciences, Science, and Technology and Medicine. From our network of offices in Oxford, New York, Philadelphia, Bangalore, Melbourne, Singapore, Beijing, Tokyo, Stockholm, New Delhi and Cape Town, Taylor & Francis staff provide local expertise and support to our editors, societies and authors and tailored, efficient customer service to our library colleagues. Taylor & Francis Group publishes more than 2,500 journals and over 5,000 new books each year, with a books backlist of approximately 130,000 specialist titles. We are providers of quality information and knowledge that enable our customers to perform their jobs efficiently, continue their education, and help contribute to the advancement of their chosen markets. Taylor & Francis is an Informa business. Informa is a multinational information provider for the academic, professional and commercial markets with offices in over 40 countries. Find out more about Informa here: http://www.informa.com/ Please note, this is not a customer service account, for customer service please go here: https://authorservices.taylorandfrancis.com/contact/ Sign up to our newsletter to receive bi-weekly updates on the most relevant new research articles as well as wider news and resources from us, straight to your inbox. https://taylorandfrancis.formstack.com/forms/tf_signup_li

Founded 1798